Temasek Holdings to Increase Investment in Celltrion

Posted on 06/24/2013


Singapore’s Temasek Holdings plans to invest US$ 129 million in Celltrion Inc., a Korean biotechnology company. Temasek Holdings is the number two shareholder in Celltrion at a 10.5% stake. The Singapore sovereign fund is also the third largest shareholder in Celltrion Healthcare Co. at a 7.7% stake. Founder, Seo Jung-jin plans to sell his stakes […]